AU5181998A - Method and reagent for inhibiting viral replication - Google Patents

Method and reagent for inhibiting viral replication

Info

Publication number
AU5181998A
AU5181998A AU51819/98A AU5181998A AU5181998A AU 5181998 A AU5181998 A AU 5181998A AU 51819/98 A AU51819/98 A AU 51819/98A AU 5181998 A AU5181998 A AU 5181998A AU 5181998 A AU5181998 A AU 5181998A
Authority
AU
Australia
Prior art keywords
reagent
viral replication
inhibiting viral
inhibiting
replication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU51819/98A
Other versions
AU729657B2 (en
Inventor
Kenneth G. Draper
Lech W. Dudycz
James J. Holecek
Dennis G. Macejak
J. Anthony Mamone
James A McSwiggen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirna Therapeutics Inc
Original Assignee
Ribozyme Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU42229/93A external-priority patent/AU687736B2/en
Application filed by Ribozyme Pharmaceuticals Inc filed Critical Ribozyme Pharmaceuticals Inc
Priority to AU51819/98A priority Critical patent/AU729657B2/en
Publication of AU5181998A publication Critical patent/AU5181998A/en
Application granted granted Critical
Publication of AU729657B2 publication Critical patent/AU729657B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU51819/98A 1992-05-11 1998-01-12 Method and reagent for inhibiting viral replication Ceased AU729657B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU51819/98A AU729657B2 (en) 1992-05-11 1998-01-12 Method and reagent for inhibiting viral replication

Applications Claiming Priority (30)

Application Number Priority Date Filing Date Title
US882824 1986-07-07
US882689 1992-05-11
US882712 1992-05-14
US882921 1992-05-14
US882922 1992-05-14
US882823 1992-05-14
US884436 1992-05-14
US882889 1992-05-14
US882713 1992-05-14
US883849 1992-05-14
US884521 1992-05-14
US884073 1992-05-14
US884074 1992-05-14
US884431 1992-05-14
US884333 1992-05-14
US882888 1992-05-14
US884422 1992-05-14
US923738 1992-07-31
US935854 1992-08-26
US936086 1992-08-26
US963322 1992-10-15
US987133 1992-12-07
US987129 1992-12-07
US987130 1992-12-07
AU42229/93A AU687736B2 (en) 1992-05-11 1993-04-29 Method and reagent for inhibiting viral replication
US882714 1997-06-25
US882886 1997-06-26
US883823 1997-06-27
AU51819/98A AU729657B2 (en) 1992-05-11 1998-01-12 Method and reagent for inhibiting viral replication
US948359 2007-11-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU42229/93A Division AU687736B2 (en) 1992-05-11 1993-04-29 Method and reagent for inhibiting viral replication

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU72549/00A Division AU7254900A (en) 1992-05-11 2000-12-28 Method and reagent for inhibiting viral replication

Publications (2)

Publication Number Publication Date
AU5181998A true AU5181998A (en) 1998-06-11
AU729657B2 AU729657B2 (en) 2001-02-08

Family

ID=3729490

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51819/98A Ceased AU729657B2 (en) 1992-05-11 1998-01-12 Method and reagent for inhibiting viral replication

Country Status (1)

Country Link
AU (1) AU729657B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9243022B2 (en) 2012-12-21 2016-01-26 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9422323B2 (en) 2012-05-25 2016-08-23 Janssen Sciences Ireland Uc Uracyl spirooxetane nucleosides

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10544184B2 (en) 2012-05-25 2020-01-28 Janssen Sciences Ireland Unlimited Company Uracyl spirooxetane nucleosides
US10301347B2 (en) 2012-05-25 2019-05-28 Janssen Sciences Ireland Unlimited Company Uracyl spirooxetane nucleosides
US9422323B2 (en) 2012-05-25 2016-08-23 Janssen Sciences Ireland Uc Uracyl spirooxetane nucleosides
US9845336B2 (en) 2012-05-25 2017-12-19 Janssen Sciences Ireland Uc Uracyl spirooxetane nucleosides
US10040814B2 (en) 2012-05-25 2018-08-07 Janssen Sciences Ireland Uc Uracyl spirooxetane nucleosides
US10774106B2 (en) 2012-05-25 2020-09-15 Janssen Sciences Ireland Unlimited Company Uracyl spirooxetane nucleosides
US10144755B2 (en) 2012-12-21 2018-12-04 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9249174B2 (en) 2012-12-21 2016-02-02 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US10683320B2 (en) 2012-12-21 2020-06-16 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9243022B2 (en) 2012-12-21 2016-01-26 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US10487104B2 (en) 2012-12-21 2019-11-26 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US10112966B2 (en) 2012-12-21 2018-10-30 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US10793591B2 (en) 2012-12-21 2020-10-06 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US11485753B2 (en) 2012-12-21 2022-11-01 Janssen Pharmaceutica Nv Substituted nucleosides, nucleotides and analogs thereof

Also Published As

Publication number Publication date
AU729657B2 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
EP0642589A4 (en) Method and reagent for inhibiting viral replication.
AU1566595A (en) Method and reagent for inhibiting hepatitis c virus replication
AU3383193A (en) Teamwork CAD system and process for teamwork designing
AU675671B2 (en) System and method for knowledge based design
AU4230193A (en) Method and system for topograhic measurement
HK1025161A1 (en) System and method for register renaming
AU6859094A (en) Method and system for geometry measurement
AU2868495A (en) Controlled denitrification process and system
AU4433693A (en) Control method and system
AU1510792A (en) Wax-encapsulated particles and method for making same
AU6239894A (en) A method and system for sampling and determining the presence of compounds
AU4785096A (en) Method and security system for ensuring the security of a de vice
AU5954994A (en) Granulable container means and method
AU5004293A (en) Toxic remediation system and method
AU6774294A (en) Methods of preventing viral replication
PL314593A1 (en) Evaporating means and method
AU4489693A (en) Apparatus and methods for improved construction
AU5339394A (en) Method and apparatus for bioaffinity assays
AU587411B2 (en) System and method for detecting flames
AU7795191A (en) Vapor clarification system and method
AU3563589A (en) Cosmetic-based means and method for removing tattooing
AU4713193A (en) Electrodialyzer and process for desalination
AU2006895A (en) Waste handling method
AU5181998A (en) Method and reagent for inhibiting viral replication
AU5777790A (en) Method of and reagent for the prevention of turbidity

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)